Phase III randomized trial of maintenance pegylated liposomal doxorubicin (PLD) / carboplatin versus without in patients with advanced ovarian cancer: An Asian Gynecologic Oncology Group study.

被引：1

作者：

Lai, Chyong-Huey

Vallikad, Elizabeth

Lin, Hao

Yang, Lan-Yan

Ou, Yu-Che

Chou, Hung-Hsueh

Lin, Cheng-Tao

Huang, Huei-Jean

Huang, Kung-Gen

Qiu, Jentai

Hung, Yao-Ching

Wu, Tzu-I

机构：

[1] Chang Gung Mem Hosp, Dept OB GYN, Taoyuan, Taiwan

[2] St Johns Med Coll, Bangalore, Karnataka, India

[3] Kaohsiung Chang Gung Mem Hosp, Chang Gung Univ Coll Med, Dept Obstet & Gynecol, Chang Gung Mem Hosp, Kaohsiung, Taiwan

[4] Chang Gung Mem Hosp, Biostatist & Informat Unit, Clin Trial Ctr, Taoyuan, Taiwan

[5] Chang Gung Mem Hosp, Chiayi Branch, Chang Gung Univ Coll Med, Dept Obstet & Gynecol, Chiayi, Taiwan

[6] Chang Gung Mem Hosp, Chang Gung Univ Coll Med, Dept Obstet & Gynecol, Taoyuan, Taiwan

[7] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan

[8] Chang Gung Mem Hosp, Chang Gung Univ Coll Med, Taoyuan, Taiwan

[9] Chang Gung Mem Hosp, Chang Gung Univ Coll Med, Dept Obstet & Gynecol, Linkou Branch, Taoyuan, Taiwan

[10] Chang Gung Mem Hosp, Chang Gung Univ Coll Med, Linkou Branch, Dept Obstet & Gynecol, Taoyuan, Taiwan

[11] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan

[12] Taipei Med Univ, Wan Fang Hosp, Dept Obstet & Gynecol, Taipei, Taiwan

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.5584

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5584

引用

页数：1